Ascletis Pharma, Inc. (1672) Income Statement

9 Followers

Ascletis Pharma, Inc. Income Statement

Last quarter (Q4 2025), Ascletis Pharma, Inc.'s total revenue was ¥931.20K, a decrease of -90.77% from the same quarter last year. In Q4, Ascletis Pharma, Inc.'s net income was ¥-267.39M. See Ascletis Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Total Revenue	¥ 1.98M	¥ 1.28M	¥ 56.60M	¥ 54.09M	¥ 76.88M
Gross Profit	¥ -16.65M	¥ 735.00K	¥ 25.99M	¥ -24.69M	¥ 39.17M
Operating Expenses	¥ 454.59M	¥ 296.15M	¥ 150.29M	¥ 319.29M	¥ 264.14M
Depreciation and Amortization	¥ 17.16M	¥ 14.18M	¥ 18.48M	¥ 30.19M	¥ 29.55M
EBITDA	¥ -454.08M	¥ -390.45M	¥ -126.09M	¥ -284.50M	¥ -169.35M
Operating Income	¥ -471.24M	¥ -295.42M	¥ -300.21M	¥ -343.98M	¥ -224.97M
Other Income/Expenses	¥ 121.16M	¥ -5.52M	¥ 0.00	¥ 29.13M	¥ 25.95M
Pretax Income	¥ -350.07M	¥ -300.94M	¥ -144.72M	¥ -314.84M	¥ -199.02M
Net Income	¥ -350.57M	¥ -300.94M	¥ -144.72M	¥ -314.84M	¥ -199.02M
Per Share Metrics
Basic EPS	¥ -0.36	¥ -0.30	¥ -0.13	¥ -0.29	¥ -0.18
Diluted EPS	¥ -0.36	¥ -0.30	¥ -0.13	¥ -0.29	¥ -0.18
Weighted Average Shares Outstanding	972.51M	1.00B	1.07B	1.09B	1.10B
Weighted Average Shares Outstanding (Diluted)	972.51M	1.00B	1.07B	1.09B	1.10B

Currency in CNY

Ascletis Pharma, Inc. (1672) Income Statement

Ascletis Pharma, Inc. Income Statement

Ascletis Pharma, Inc. Earnings and Revenue History